The role focuses on accelerating the impact of tersolisib, a selective PI3Ki currently in late-phase development for breast cancer.
Base: $198,000 - $356,400; Bonus: Company bonus depending on performance; Benefits: Comprehensive program including 401(k), pension, medical, dental, vision, life insurance, and wellness benefits
Must-have
Nice-to-have
Not specified